Spinach saponin-enriched fraction inhibits platelet aggregation in cAMP- and cGMP-dependent manner by decreasing TXA2 production and blood coagulation

Biomolecules and Therapeutics

Volumn 19, Issue 2, 2011, Pages 218-223

  Cho, Hyun Jeong ^a   Choi, Sun A ^b,f   Kim, Chun Gyu ^b   Jung, Tae Sung ^c   Hong, Jeong Hwa ^b   Rhee, Man Hee ^d   Park, Hye Jin ^e   Park, Hwa Jin ^a  

^a Konyang University   (South Korea)

^b Inje University   (South Korea)

^c Kungsung University   (South Korea)

^d Kyungpook National University   (South Korea)

^e Konkuk University   (South Korea)

^f Pusan National University Hospital   (South Korea)

Author keywords

Blood coagulation; Platelet aggregation; Spinach saponin enriched fraction (SSEF); Thrombotic diseases

Indexed keywords

ANTICOAGULANT AGENT; CALCIUM ION; COLLAGEN; CYCLIC AMP; CYCLIC GMP; GINSENG SAPONIN; SPINACH SAPONIN ENRICHED FRACTION; THROMBOXANE A2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; CALCIUM CELL LEVEL; CONTROLLED STUDY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RAT; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

SPINACIA OLERACEA;

EID: 79956107764     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2011.19.2.218     Document Type: Article

References (29)

1. Afolayan, A. J. and Jimoh, F. O. (2009) Nutritional quality of some wild leafy vegetables in South Africa. Intl. J. Food Sci. Nutr. 60, 424-431.
2. Akoum, A., Josefonvicz, J. and Sigot, M. (1990). Anticoagulant activity of a bacterial glycopeptide. Thromb. Res. 60, 9-18.
3. Bergman, M., Varshavsky, L., Gottlieb, H. E. and Grosman, S. (2001) The antioxidant activity of aqueous spinach extract: chemical identify cation of activity fractions. Phytochemistry 58, 143-152.
4. Cattaneo, M., Tenconi, P. M., Lecchi, A. and Mannucci, P. M. (1991) In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Thromb. Res. 62, 717-724.
5. Charo, I. F., Feinman, R. D. and Detwiler, T. C. (1997) Interrelations of platelet aggregation and secretion. J. Clin. Invest. 60, 866-873.
6. Cho, H. J., Ham, H. S., Lee, T. K., Jung, Y. J., Choi, S. A., Kang, H. C. and Park, H. J. (2004) Inhibitory effect of cordycepin on human platelet aggregation. J. Biomed. Lab. Sci. 10, 1-8.
7. Davie, E. W. and Ratnoff, O. D. (1964) Waterfall sequence for intrinsic blood clotting. Science 145, 1310-1312.
8. Dogné, J. M., de Leval, X., Hanson, J., Frederich, M., Lambermont, B., Ghuysen, A., Casini, A., Masereel, B., Ruan, K. H., Pirotte, B. and Kolh, P. (2004) New developments on thromboxane and prostacylcin modulators part I: thromboxane modulators. Curr. Med. Chem. 11, 1223-1241.
9. Edwards, A. J., You, C. S., Swanson, J. E. and Parker, R. S. (2001) A novel extrinsic reference method for assessing the vitamin A of plant foods. Am. J. Clin. Nutr. 74, 348-355.
10. Furie, B. and Furie, B. C. (1988) The molecular basis of blood coagulation. Cell 53, 505-518.
11. Gorman, R. R., Johnson, R. A., Spilman, C. H. and Aiken, J. W. (1983) Inhibition of platelet thromboxane A2 synthase activity by sodium 5-(3'-pyridinylmethyl)benzofuran-2-carboxylate. Prostaglandins 26, 325-342.
12. Hamberg, M., Svensson, J. and Samuelsson, B. (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc. Natl. Acad. Sci. 72, 2994-2998.
13. Hanson, J., Rolin, S., Reynaud, D., Qiao, N., Kelley, L. P., Reid, H. M., Valentin, F., Tippins, J., Kinsella, B. T., Masereel, B., Pace-Asciak, C., Pirotte, B. and Dogné, J. M. (2005) In vitro and in vivo pharmacological characterization of BM-613 [N-n-pentyl-N'-[2-(4'-methylphenylamino)-5-nitrobenzenesulfonyl] urea], a novel dual thromboxane synthase inhibitor and thromboxane receptor antagonist. J. Pharmacol. Exp. Ther. 313, 293-301.
14. Jang, E. K., Azzam, J. E., Cickinson, N. T., Davidson, M. M. and Haslam, R. J. (2002) Roles for both cyclic GMP and cyclic AMP in the inhibition of collagen-induced platelet aggregation by nitroprusside. Br. J. Haematol. 117, 664-675.
15. Kimura, Y., Okuda, H. and Arichi, S. (1988) Effects of various ginseng saponins on 5-hydroxytryptamine release and aggregation in human platelets. J. Pharm. Pharmacol. 40, 838-843.
16. Lomnitski, L., Bergman, M., Nyska, A., Ben-Shaul, V. and Grosman, S. (2003) Composition, effi cacy, and safety of spinash extracts. Nutr Cancer. 46, 222-231.
17. Moncada, S. and Vane, J. R. (1978) Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol. Rev. 30, 293-331.
18. Moon, M. K., Ahn, J. Y., Kim, S., Ryu, S. Y., Kim, Y. S. and Ha, T. Y. (2010) Ethanol extract and saponin of Platycodon grandifl orum ameliorate scopolamine-induced amnesia in mice. J. Med. Food. 13, 584-588.
19. Nishikawa, M., Tanaka, T. and Hidaka, H. (1980) Ca2+-calmodulindependent phosphorylation and platelet secretion. Nature 287, 863-865.
20. Podolak, I., Galany, A. and Sobolewska, D. (2010) Saponins as cytotoxic agents: a review. Phytochem. Rev. 9, 425-474.
21. Prinz-Langenohl, R., Bronstrup, A., Thorand, B., Hages, M. and Pietrzik, K. (1999) Availability of food folate in humans. J. Nutr. 129, 913-916.
22. Sani, H. A., Rahat, A., Ismail, M., Rosli, R. and Endrini, S. (2004) Potential anticancer effect of red spinach (Amaranthus gangeticus) extract. Asia Pac. J. Clin. Nutr. 13, 396-400.
23. Sano, Y., Sato, K., Uchida, M. and Murata, M. (2003) Blood coagulation fi brinolysis of rats fed fi sh oil: reduced coagulation factors especially involved in intrinsic pathway and increased activity of plasminogen activator inhibitor. Biosic. Biotechnol. Biochem. 67, 2100-2105.
24. Schwartz, S. M., Heinmark, R. L. and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70, 1177-1209.
25. Schwarz, U. R., Walter, U. and Eigenthaler, M. (2001) Taming platelets with cyclic nucleotides. Biochem. Pharmaco. 62, 1153-1161.
26. Sinha, A. K., Rao, A. K., Willis, J. and Colman, R. W. (1983) Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa. Proc. Natl. Acad. Sci. USA. 80, 6086-6090.
27. Stegmeier, K., Pill, J., Muller-Beckmann, B., Schmidt, F. H., Witte, E. C., Wolff, H. P. and Patscheke, H. (1984) The pharmacological profi le of the thromboxane A2 antagonists BM 13.177. A new antiplatelet and anti-thrombotic drug. Thromb. Res. 35, 379-395.
28. Sudo, T., Ito, H. and Kimura, Y. (2003) Phosphorylation of the vasodilator- stimulated phosphoprotein (VASP) by the antiplatelet drug, cilostazol, in platelets. Platelets 14, 381-390.
29. Tsai, Y. C., Lin, C. L. and Chen, B. H. (2010) Preparative chromatography of fl avonoids and saponins in Gynostemma pentaphyllum and their antiploliferation effect on hepatoma cell. Phytomedicine. 18, 2-10.